KB105
KB105-001
Phase 2 mab active
Quick answer
KB105 for TGM-1 Related Autosomal Recessive Congenital Ichthyosis is a Phase 2 program (mab) at Krystal Biotech Netherlands B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Krystal Biotech Netherlands B.V.
- Indication
- TGM-1 Related Autosomal Recessive Congenital Ichthyosis
- Phase
- Phase 2
- Modality
- mab
- Status
- active